SCHEMBL8540415

SCHEMBL8540415

COc1ccc(OCCCCCCn2ccnc2C)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
TP53 P04637 1/20 0.47
MAPK1 P28482 1/20 0.47
S1PR4 O95977 1/20 0.45
GLA P06280 1/20 0.44
POLB P06746 1/20 0.43
MAPT P10636 4/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
ICMT O60725 1/20 0.41
LMNA P02545 1/20 0.40
HPGD P15428 3/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
NPC1 O15118 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9264976 0.86 HTT (0.43) HTTSMN1; SMN2KDM4EALDH1A1KMT2A
SCHEMBL9270152 0.85 HTT (0.42) HTTSMN1; SMN2KDM4EALDH1A1KMT2A
SCHEMBL8536773 0.81 SMN1; SMN2 (0.41) HTTSMN1; SMN2KMT2AMEN1TP53
SCHEMBL9268581 0.81 S1PR4 (0.45) HTTSMN1; SMN2KMT2AMEN1TP53
SCHEMBL8903264 0.80 MAPT (0.60) HTTSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL8538356 0.79 S1PR4 (0.39) HTTSMN1; SMN2KDM4EKMT2AMEN1
SCHEMBL9267414 0.79 MEN1 (0.72) HTTSMN1; SMN2KDM4EALDH1A1KMT2A
SCHEMBL9260326 0.79 MEN1 (0.72) HTTSMN1; SMN2KDM4EALDH1A1KMT2A
SCHEMBL8540593 0.79 S1PR4 (0.42) HTTSMN1; SMN2KDM4EALDH1A1KMT2A
SCHEMBL9266468 0.79 MEN1 (0.72) HTTSMN1; SMN2KDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4851423-A Pharmaceutically active compounds SCHERING CORPORATION (US) 1989-07-25 US claimed
EP-0274867-A2 Pharmaceutically active compounds SCHERING CORPORATION (US) 1988-07-20 EP claimed
US-5750532-A TETRAHYDROPYRIMIDINE-2,4-DIONE DERIVATIVES, VIRICIDES, ANTIINFLAMMATORY AGENTS, PAF INHIBITORS SCHERING CORPORATION (US) 1998-05-12 US disclosed
US-5459144-A Enterovirus and rhinovirus antiviral, antiinflammatory and antagonist of platelet activating factor SCHERING CORPORATION (US) 1995-10-17 US disclosed
US-5272167-A Pharmaceutically active compounds SCHERING CORPORATION (US) 1993-12-21 US disclosed
EP-0560407-A1 Pharmaceutically active compounds SCHERING CORPORATION (US) 1993-09-15 EP disclosed
WO-1991000858-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS SCHERING CORPORATION (US) 1991-01-24 WO disclosed
EP-0407217-A1 Pharmaceutically active compounds SCHERING CORPORATION (US) 1991-01-09 EP disclosed
US-4851423-A Pharmaceutically active compounds SCHERING CORPORATION (US) 1989-07-25 US disclosed
EP-0274867-A2 Pharmaceutically active compounds SCHERING CORPORATION (US) 1988-07-20 EP disclosed